Package 50458-607-01

Brand: invega trinza

Generic: paliperidone palmitate
NDC Package

Package Facts

Identity

Package NDC 50458-607-01
Digits Only 5045860701
Product NDC 50458-607
Product ID 50458-607_2e1c6fa0-3051-4a53-e063-6294a90ad1c3
Description

1 SYRINGE in 1 KIT (50458-607-01) / 1 mL in 1 SYRINGE

Marketing

Marketing Status
Marketed Since 2015-05-19
Brand invega trinza
Generic paliperidone palmitate
Sample Package No

Linked Drug Pages (1)

INVEGA TRINZA ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR"], "spl_id": "2e1c6fa0-3051-4a53-e063-6294a90ad1c3", "openfda": {"unii": ["R8P8USM8FR"], "rxcui": ["1650966", "1650968", "1650971", "1650972", "1650973", "1650974", "1650975", "1650976"], "spl_set_id": ["c39e65d7-fa44-4e4c-8b12-a654d3ed0eae"], "manufacturer_name": ["Janssen Pharmaceuticals, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 KIT (50458-607-01)  / 1 mL in 1 SYRINGE", "package_ndc": "50458-607-01", "marketing_start_date": "20150519"}], "brand_name": "INVEGA TRINZA", "product_id": "50458-607_2e1c6fa0-3051-4a53-e063-6294a90ad1c3", "dosage_form": "INJECTION, SUSPENSION, EXTENDED RELEASE", "pharm_class": ["Atypical Antipsychotic [EPC]"], "product_ndc": "50458-607", "generic_name": "paliperidone palmitate", "labeler_name": "Janssen Pharmaceuticals, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "INVEGA TRINZA", "active_ingredients": [{"name": "PALIPERIDONE PALMITATE", "strength": "410 mg/1.32mL"}], "application_number": "NDA207946", "marketing_category": "NDA", "marketing_start_date": "20150519", "listing_expiration_date": "20261231"}